{"id":5730,"date":"2026-05-14T13:00:00","date_gmt":"2026-05-14T11:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=cbf2f4b234b4449a1c507fe0a941e4c1"},"modified":"2026-05-15T02:15:00","modified_gmt":"2026-05-15T00:15:00","slug":"sofis-partners-with-arcadea-group","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=5730","title":{"rendered":"Sofis Partners with Arcadea Group"},"content":{"rendered":"

\nArcadea expands its position in Brazilian healthcare software with its fourth investment in the sector<\/i><\/p><\/a><\/a>

TORONTO & RIO DE JANEIRO--(BUSINESS WIRE)--Arcadea Group, a preeminent, long-term investor in global software businesses, today announced the acquisition of Sofis, a leading provider of mission-critical software to the Brazilian healthcare sector, focused on hemotherapy and cell therapy.<\/p>

\nFounded in Rio de Janeiro in 1986 by Reynaldo Mendes, Sofis\u2019 product portfolio includes Hemote Plus for blood bank and transfusion services management, Cellvida for cell therapy, Salute for hospital management, and solutions across diagnostic medicine, ERP, and business intelligence. Sofis serves more than 300 institutions across Brazil \u2014 including hospitals, clinics, laboratories, blood centers, and public healthcare agencies \u2014 and its software supports approximately 75,000 blood collections and 150,000 transfusions every month.<\/p>

\n\u201cWe evaluated a number of potential partners and chose Arcadea because their approach aligned with how we think about running Sofis,\u201d said Reynaldo Mendes, Founder and CEO of Sofis. \u201cThey invest with a long-term time horizon, and they understand that serving healthcare customers well requires sustained investment in product and people. Their existing portfolio companies in the healthcare space made it clear their commitment to excellence in our market. This is a significant milestone in our growth journey as we transition from a founder-owned company to one that now has the resources of a leading international player.\u201d<\/p>

\n\u201cSofis is a high-quality business with a differentiated product, deeply embedded customer relationships, and a disciplined operator at the helm,\u201d said Daniel Eisen, Co-Founder and Managing Director of Arcadea. \u201cReynaldo and his team have spent nearly four decades building software that plays a direct role in patient care across Brazil, and they have no intention of slowing down. Following our investments in Animati, Intuitive Care and WMI, Sofis extends our presence in a market where we see a meaningful opportunity for Arcadea to support companies in their long-term mission to serve healthcare providers with the highest-quality technology solutions.\u201d<\/p>

\nFor more information on Sofis, visit sofis.com.br<\/a>. For more on Arcadea Group, visit arcadeagroup.com<\/a>.<\/p>

\nAbout Sofis<\/b><\/p>

\nFounded in 1986 and headquartered in Rio de Janeiro, Sofis develops mission-critical software for the Brazilian healthcare sector. The company specializes in solutions for hemotherapy, cell therapy, hospital management, diagnostic medicine, ERP, and business intelligence, and also provides cloud, IT outsourcing, and information security services. Sofis serves more than 300 healthcare institutions across Brazil and has been recognized with national certifications and the use of international standards such as MPS.Br, ISBT, and ITIL, as well as multiple Great Place to Work awards.<\/p>

\nAbout Arcadea Group<\/b><\/p>

\nArcadea Group invests in high-quality, strongly-growing software companies over extremely long durations. Based in Toronto and Orlando and investing globally, Arcadea leverages its significant permanent capital base to focus exclusively on businesses with long-term potential and ambitions.<\/p> Contacts<\/b>

\nDaniel Eisen\nManaging Director, Arcadea Group\neisen@arcadeagroup.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

Arcadea expands its position in Brazilian healthcare software with its fourth investment in the sectorTORONTO & RIO DE JANEIRO–(BUSINESS WIRE)–Arcadea Group, a preeminent, long-term investor in global software businesses, today announced the acquisi…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-5730","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/5730","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5730"}],"version-history":[{"count":2,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/5730\/revisions"}],"predecessor-version":[{"id":6302,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/5730\/revisions\/6302"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5730"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5730"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5730"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}